CLN5 is a soluble endolysosomal protein whose function is poorly understood. Mutations in this protein cause a rare neurodegenerative disease, neuronal ceroid lipofuscinosis (NCL). We previously found that depletion of CLN5 leads to dysfunctional retromer, resulting in the degradation of the lysosomal sorting receptor, sortilin. However, how a soluble lysosomal protein can modulate the function of a cytosolic protein, retromer, is not known. In this work, we show that deletion of CLN5 not only results in retromer dysfunction, but also in impaired endolysosome fusion events. This results in delayed degradation of endocytic proteins and in defective autophagy. CLN5 modulates these various pathways by regulating downstream interactions between CLN3, an endolysosomal integral membrane protein whose mutations also result in NCL, RAB7A, and a subset of RAB7A effectors. Our data support a model where CLN3 and CLN5 function as an endolysosomal complex regulating various functions.
-
Cover Image
Cover Image
Autophagy is an important component of the innate immune response that restricts infection by different types of pathogens. In this issue Ylä-Anttila and Masucci (pp. 2297–2308) demonstrate the inhibition of selective autophagy by various members of the herpesvirus upiquitin-deconjugase family. The cover image shows representative micrographs illustrating the colocalization of SQSTM1/p62 (red) with LC3 (green) in cells expressing the viral enzymes (grey). The nuclei were stained with DAPI (blue). Size bars = 10 µm. Image provided by Maria G. Masucci.
CLN5 and CLN3 function as a complex to regulate endolysosome function
Seda Yasa, Etienne Sauvageau, Graziana Modica, Stephane Lefrancois; CLN5 and CLN3 function as a complex to regulate endolysosome function. Biochem J 25 June 2021; 478 (12): 2339–2357. doi: https://doi.org/10.1042/BCJ20210171
Download citation file:
Sign in
Sign in to your personal account
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Follow us on Twitter @Biochem_Journal
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() View past webinars > |